Abstract
Background
Little is known about the effects of socio-economic deprivation on the oncological outcomes of surgically treated upper tract transitional cell carcinoma.
Methods
From January 1998 to December 2012, 161 patients underwent nephroureterectomy for upper urinary tract cancer at our tertiary medical centre. We included 124 patients where complete data were available for further analysis. This study also analysed the impact of the reported risk factors such as grade, stage, multifocality in addition to socio-economic deprivation on the long-term oncological outcomes after nephroureterectomy.
Results
One hundred and twenty-four (77 %) patients with complete data for socio-economic status were analysed in this study. The median age of the cohort was 73 years (interquartile range 45–86). There were 20, 18, 17, 40 and 29 patients in different socio-economic categories ranging from 1 to 5, respectively. The median duration of follow-up was 68 months (9–174). A statistically higher grade (p value 0.005) and higher stage (p value 0.0005) disease was seen in patients from less deprived categories on both univariate and multivariate analyses. The cancer-specific mortality and follow-up recurrences, however, did not significantly differ between the different socio-economic categories on multivariate analysis (p value 0.13; 0.6) and on univariate and multivariate analyses. A higher number of patients with multifocal disease and concomitant carcinoma in situ (CIS) had disease recurrences which were statistically significant (p values 0.026 and 0.014, respectively) on multivariate analysis.
Conclusions
A lower recurrence-free survival was observed in patients with multifocal disease and those with concomitant CIS following nephroureterectomy for clinically localized disease. Long-term follow-up did not show any significant differences in cancer-specific survival between different deprivation categories.
Similar content being viewed by others
References
Rai BP, Shelley M, Coles B, Somani B, Nabi G (2012) Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. BJU Int 110:1426–1435
Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594–601
Eylert MF, Hounsome L, Verne J, Bahl A, Jefferies ER, Persad RA (2013) Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985-2010. BJU Int 112:E107–E113
Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Brenner H, Esteve J (2004) Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90:1367–1373
Ayanian JZ, Carethers JM (2012) Bridging behavior and biology to reduce socioeconomic disparities in colorectal cancer risk. J Natl Cancer Inst 104:1343–1344
Akinyemiju TF, Soliman AS, Johnson NJ, Altekruse SF, Welch K, Banerjee M, Schwartz K, Merajver S (2013) Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities. J Cancer Epidemiol 2013:490472
Kahn KL, Pearson ML, Harrison ER, Desmond KA, Rogers WH, Rubenstein LV, Brook RH, Keeler EB (1994) Health care for black and poor hospitalized Medicare patients. JAMA 271:1169–1174
Moore RD, Stanton D, Gopalan R, Chaisson RE (1994) Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 330:763–768
Yergan J, Flood AB, LoGerfo JP, Diehr P (1987) Relationship between patient race and the intensity of hospital services. Med Care 25:592–603
Evans R, Roos NP (1999) What is right about the Canadian health care system? Milbank Q 77(393–9):276
Starfield B (2000) Is US health really the best in the world? JAMA 284:483–485
Starfield B, Paganini JM (2000) Is equity a scientific issue? J Epidemiol Community Health 54:324–325
Susser M (1993) Health as a human right: an epidemiologist’s perspective on the public health. Am J Public Health 83:418–426
Marmot MG, Kogevinas M, Elston MA (1987) Social/economic status and disease. Annu Rev Public Health 8:111–135
Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22:1435–1448
Gillan A, Alexander E, Townell N, Nabi G (2013) Laparoscopic en bloc resection of ureter with a cuff of bladder during radical nephroureterectomy for lower ureteric tumors: a matched-paired analysis. J Laparoendosc Adv Surg Tech A 23:626–631
Leonard M, Tait CD, Gillan AS, Rai BP, Byrne DJ, Nabi G, TUCAN Group in Tayside (2013) Impact of multiple deprivations on detection, progression and interventions in small renal masses (less than 4 cm) in a population based study. Eur J Surg Oncol
Morgan RM, Steele RJ, Nabi G, McCowan C (2013) Socioeconomic variation and prostate specific antigen testing in the community: a united kingdom based population study. J Urol
Oliphant R, Nicholson GA, Horgan PG, Molloy RG, McMillan DC, Morrison DS, West of Scotland Colorectal Cancer Managed Clinical Network (2013) Deprivation and colorectal cancer surgery: longer-term survival inequalities are due to differential postoperative mortality between socioeconomic groups. Ann Surg Oncol 20:2132–2139
Ganeswaran D, Sweeney C, Yousif F, Lang S, Goodman C, Nabi G (2012) Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer. World J Urol
El-Mokadem I, Budak M, Pillai S, Lang S, Doull R, Goodman C, Nabi G (2013) Progression, interobserver agreement, and malignancy rate in complex renal cysts (Bosniak category IIF). Urol Oncol
Hagiwara M, Kikuchi E, Tanaka N, Matsumoto K, Ide H, Miyajima A, Masuda T, Nakamura S, Oya M (2013) Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. J Urol 189:2062–2068
Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF, Schwartz SM, Chen VW, Bernstein L, Gomez SL, Graff JJ, Lin CC, Johnson NJ, Edwards BK (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national Longitudinal Mortality Study. Cancer Causes Control 20:417–435
Kogevinas M, Porta M (1997) Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ 138:177–206
Woods LM, Rachet B, O’Connell DL, Lawrence G, Tracey E, Willmore A, Coleman MP (2010) Differences in breast cancer incidence in Australia and England by age, extent of disease and deprivation status: women diagnosed 1980-2002. Aust N Z J Public Health 34:206–213
Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS, Shariat SF (2013) Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 189:1214–1221
Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54:1127–1134
Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61:245–253
Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration (2013) Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol 63:1082–1090
Ehdaie B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, Coleman JA, Dalbagni G (2013) Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU Int 111:589–595
Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE (2008) Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol Biomarkers Prev 17:938–944
Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL (1999) Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91:605–613
Zeegers MP, Kellen E, Buntinx F, van den Brandt PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 21:392–401
Begum G, Dunn JA, Bryan RT, Bathers S, Wallace DM, West Midlands Urological Research Group (2004) Socio-economic deprivation and survival in bladder cancer. BJU Int 94:539–543
Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L, Latour M, Widmer H, Duclos A, Benard F, McCormack M, Montorsi F, Karakiewicz PI (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology 75:321–327
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655
Conflict of interest
None
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Mehta, R., Gillan, A.S., Ming, Z.Y. et al. Socio-economic deprivation and outcomes following radical nephroureterectomy for clinically localized upper tract transitional cell carcinoma. World J Urol 33, 41–49 (2015). https://doi.org/10.1007/s00345-014-1262-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-014-1262-0